Psoriatic Arthritis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Secukinumab (Cosentyx ®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artificial Intelligence (SpAINET): Spanish Multicenter, Retrospective, Real World Evidence Study
Conditions: Axial Spondyloarthritis; Psoriatic Arthritis Intervention: Drug: secukinumab Sponsor: Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2023 Category: Research Source Type: clinical trials